My Pick: AMLX — But This Is a -To The Moon - Tiger Brokers Online Investing Community

My Pick: AMLX — But This Is a Catalyst Trade

If I had to pick one for the next 30 days, I’d choose Amylyx Pharmaceuticals (AMLX) — not because it is the safest name, but because it has the clearest near-term binary catalyst.

The stock has already exploded higher, so chasing momentum here is risky. But the real story is still ahead: Amylyx expects Phase 3 LUCIDITY results for avexitide in late August or early September. A positive readout could materially change the company’s valuation and potentially support a 2027 commercial launch.

That makes AMLX fundamentally different from simply buying a beaten-down stock like Adobe or Intuit.

My choice: 🔥 Momentum, with a catalyst-driven setup.

The key is position sizing — this is biotech, so one clinical result can create either a breakout or a brutal reversal.

@TigerPicks [真香]

💰Stocks to watch today?(20 August）

1. What news/movements are worth noting in the market today? Any stocks to watch? 2. What trading opportunities are there? Do you have any plans? 🎁 Make a post here, everyone stands a chance to win Tiger coins!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

dimzy5
08-19 20:12
dimzy5
Market already priced in a lot of success here. Binary setup, sure, but after this run the downside on a miss feels nastier than the upside.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":598475529831680,"tweetId":"598475529831680","gmtCreate":1787138878590,"gmtModify":1787138882725,"author":{"id":4194184698932812,"idStr":"4194184698932812","authorId":4194184698932812,"authorIdStr":"4194184698932812","name":"苏36","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"9427a906234c4b18a82ec3d7730b7fa8-1","templateUuid":"9427a906234c4b18a82ec3d7730b7fa8","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://community-static.tradeup.com/news/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://community-static.tradeup.com/news/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://ttm.financial/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.08.20","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"wearingBadges":[],"fanSize":961,"starInvestorFlag":false},"themes":[{"themeId":"470d3ab575ca43caaed8156645b7ccbe","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"💰Stocks to watch today?(20 August）","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":470d3ab575ca43caaed8156645b7ccbe}&rnconfig={\"headerBarHidden\": true}","description":"1. What news/movements are worth noting in the market today? Any stocks to watch? \n2. What trading opportunities are there? Do you have any plans?\n🎁 Make a post here, everyone stands a chance to win Tiger coins!","image":"https://static.tigerbbs.com/cd8eaff2e99964ab7a80d92cc196fcd3"}],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body>My Pick: AMLX — But This Is a Catalyst Trade\n\nIf I had to pick one for the next 30 days, I’d choose Amylyx Pharmaceuticals (AMLX) — not because it is the safest name, but because it has the clearest near-term binary catalyst.\nThe stock has already exploded higher, so chasing momentum here is risky. But the real story is still ahead: Amylyx expects Phase 3 LUCIDITY results for avexitide in late August or early September. A positive readout could materially change the company’s valuation and potentially support a 2027 commercial launch.\nThat makes AMLX fundamentally different from simply buying a beaten-down stock like Adobe or Intuit.\nMy choice: 🔥 Momentum, with a catalyst-driven setup.\nThe key is position sizing — this is biotech, so one clinical result can create either a breakout or a brutal reversal.\n<a href=\"https://ttm.financial/U/9000000000000572\"> @TigerPicks </a> [真香]</body></html>","htmlText":"<html><head></head><body>My Pick: AMLX — But This Is a Catalyst Trade\n\nIf I had to pick one for the next 30 days, I’d choose Amylyx Pharmaceuticals (AMLX) — not because it is the safest name, but because it has the clearest near-term binary catalyst.\nThe stock has already exploded higher, so chasing momentum here is risky. But the real story is still ahead: Amylyx expects Phase 3 LUCIDITY results for avexitide in late August or early September. A positive readout could materially change the company’s valuation and potentially support a 2027 commercial launch.\nThat makes AMLX fundamentally different from simply buying a beaten-down stock like Adobe or Intuit.\nMy choice: 🔥 Momentum, with a catalyst-driven setup.\nThe key is position sizing — this is biotech, so one clinical result can create either a breakout or a brutal reversal.\n<a href=\"https://ttm.financial/U/9000000000000572\"> @TigerPicks </a> [真香]</body></html>","text":"My Pick: AMLX — But This Is a Catalyst Trade If I had to pick one for the next 30 days, I’d choose Amylyx Pharmaceuticals (AMLX) — not because it is the safest name, but because it has the clearest near-term binary catalyst. The stock has already exploded higher, so chasing momentum here is risky. But the real story is still ahead: Amylyx expects Phase 3 LUCIDITY results for avexitide in late August or early September. A positive readout could materially change the company’s valuation and potentially support a 2027 commercial launch. That makes AMLX fundamentally different from simply buying a beaten-down stock like Adobe or Intuit. My choice: 🔥 Momentum, with a catalyst-driven setup. The key is position sizing — this is biotech, so one clinical result can create either a breakout or a brutal reversal. @TigerPicks [真香]","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/598475529831680","repostId":0,"isVote":1,"tweetType":1,"viewCount":129,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":695,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":598486174835488,"commentId":"598486174835488","gmtCreate":1787141554377,"gmtModify":1787190837083,"authorId":9000000000000187,"author":{"id":9000000000000187,"idStr":"9000000000000187","authorId":9000000000000187,"name":"dimzy5","avatar":"https://static.tigerbbs.com/c05637de10fca666e37d2c570e52012a","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[]},"repliedAuthorId":0,"objectId":598475529831680,"objectIdStr":"598475529831680","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Market already priced in a lot of success here. Binary setup, sure, but after this run the downside on a miss feels nastier than the upside.","text":"Market already priced in a lot of success here. Binary setup, sure, but after this run the downside on a miss feels nastier than the upside.","html":"Market already priced in a lot of success here. Binary setup, sure, but after this run the downside on a miss feels nastier than the upside.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/598475529831680"}